Research Article
[Retracted] Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery
Table 4
Comparison of VEGF, CDF-1, and IL-6 levels before and after treatment.
| Group | VEGF | SDF-1 | IL-6 | Before treatment | 3 months after treatment | Before treatment | 3 months after treatment | Before treatment | 3 months after treatment |
| Conbercept group (N = 176) | 312.46 ± 40.88a | 180.43 ± 29.01 | 903.46 ± 65.25a | 485.23 ± 83.55 | 13.17 ± 3.01a | 9.04 ± 3.64 | Triamcinolone acetonide group (N = 174) | 310.87 ± 45.25a | 206.91 ± 19.87 | 911.64 ± 60.61a | 511.72 ± 78.56 | 12.56 ± 2.74a | 9.92 ± 2.66 | T | 0.269 | 7.736 | 0.947 | 2.381 | 1.544 | 2.007 | P value | 0.788 | <0.001 | 0.345 | 0.018 | 0.124 | 0.046 |
|
|
Compared with that before treatment, a. |